New daily pill ZT006 shows promise for weight loss in early human trial
NCT ID NCT07307638
First seen Jan 11, 2026 · Last updated May 23, 2026 · Updated 21 times
Summary
This early-stage study tested ZT006, an experimental daily pill for weight loss, in 94 healthy overweight and obese adults. The main goal was to check safety and how the drug moves through the body. Participants received either the drug or a placebo, with doses increased over time. Results will help decide if larger studies are warranted.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERWEIGHT , OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Second Affiliated Hospital of Anhui Medical University
Hefei, Anhui, 230601, China
Conditions
Explore the condition pages connected to this study.